Brief: Statera Biopharma Announces Pricing Of $5.7 Mln Underwritten Public Offering
March 22 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA ANNOUNCES PRICING OF $5.7
MILLION UNDERWRITTEN
PUBLIC OFFERING
* STATERA BIOPHARMA - ANNOUNCED PRICING OF ITS UNDERWRITTEN
PUBLIC
OFFERING OF ABOUT 10,843,721 UNITS, AT A PRICE TO PUBLIC OF
$0.45 PER UNIT
* STATERA BIOPHARMA - PRICING OF ITS UNDERWRITTEN PUBLIC
OFFERING
OF ABOUT 1.7 MILLION PRE-FUNDED UNITS, AT PRICE TO PUBLIC OF
$0.44 PER PRE-FUNDED UNIT
Source text for Eikon: ID:nGNXc662gQ
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc